On the afternoon of July 27, Dr. Nguyen Ngo Quang, Deputy Director of the Department of Science and Technology and Training (Ministry of Health) said, there are 3 technological transfer contracts related to the Covid-19 vaccine with Russia, USA, Japan has been signed 9: 00/4: 03 nam nam names machining and closing vaccines Covid-19 Sputnik-V in Vietnam by Vabiotech photo: Long PhamThe, Vababiotech with ancient company The International Advancement (AIC) and Shionogi Japan Company, signed an agreement to transfer the technology to produce Covid-19 vaccine production. Vaccine technology is transferred as Recombinant SARS-COV-2 spike protein, instant recombinant vaccine production technology. Currently, the parties signed a security agreement to access vaccine and technology records. Before that, the Minister of Health issued Decision No
. 2301 / QD-BYT to establish a Steering Committee of the Transfer Program Transfer technology and produce Covid-19 room vaccine. Accordingly, the first project is a technology transfer cooperation between AIC Company and Shionogi Company (Japan) and Vaccines according to MNRA technology. The health has signed a cooperation agreement, preparing Planning to implement phase 3 clinical trial research in Vietnam (clue is the Institute of Epidemiological Hygiene and Epidemia) and doing technology transfer procedures (the clue is Vabiotech)
It is expected that June 6/2022 will complete the activities and bring the vaccine to the market. The second project is the technology transfer between DS-BIO company, Vaccin and Vaccination Company Limited and No. 1 ( Vabaotech) and the Federal Federal Direct Investment Fund. The agreement signed an agreement with the Russian Federal Direct Investment Fund for the Putnik-V vaccine tube from semi-finished products. Vabaotech has built a pipe and sent a sample to the Russian Federation for quality inspection, expected to 10/8 will have test results, then can proceed with a tube with a scale of 5 million doses per month (inside August can begin with a minimum of 500,000 doses), proceeding to transfer production technology with a scale of 100 million doses per year. Conditions for businesses to access vaccines Recently have many businesses, The organization proposes to allow negotiated, sourcing and importing Covid-19 vaccines for free injections for people; Please keep partially with vaccines after contributing to the Covid-19 Vietnam Vaccine Fund. Before this issue, Prime Minister Pham Minh Chinh asked the Minister of Health to continue to direct, support and have documents guiding localities and businesses to access vaccine supplies in the world. At the same time, it is responsible for state management of the quality of vaccines, licensing, preservation and organization of timely injection, science, safety and efficacy. In addition, the Prime Minister asked the Ministry of Health to have a written guiding and implementing the priority on the use of vaccines for organizations and individuals who transfer funds to fund Vaccine Room Covid- 19 Vietnam. For the project to study technology transfer with the US, currently the Ministry of Health has sent a group of experts to coordinate with the World Health Organization (WHO) supporting relevant units Phase 1-2-3 clinical trial records according to the shortened process, expected to launch research on 1/8 and end at the end of December
Technology transfer and finishing vaccine factory Please in Vietnam will be completed in June 2022.Hai "Made in Vietnam" vaccine to the new period, according to the information from the Military Medical Academy, after completing the 2 injection for 1,000 volunteers ( Phase 3A), in the morning of July 27, the centers participated in the study of Nano Covax vaccine injecting nose 2 for 12,000 volunteers (in the 3b period). Assoc.Propy Chu Van Truong, Director of the Center for Clinical Trials and Biological Equivalence, Military Medical Academy said before the test injection, volunteers must declare medical and medical examinations Number of survival signs, pregnancy tests for female volunteers in reproductive age, then in front of the injection. So far, there are 2 Covid-19 vaccine vaccines. Clinical trials. In addition to the Nano Covax vaccine, there is a Covivac vaccine of the Institute of Vaccine and Medical Biology. The Covivac vaccine has completed 2 vaccines in phase 1 for 120 volunteers from 18-59 years old , with the main goal is to evaluate the initial safety on volunteers and choose the three most suitable formulas to switch to stage 2. Safety rating results No serious disadvantages, variables Disadvantage is mainly at level 1, recovering quickly after injection. . Dịch vụ:
Thiết kế website,
quảng cáo google,
đăng ký website bộ công thương uy tín
